[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Schrodinger Inc (SDGR)

Schrodinger Inc (SDGR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,376,836
  • Shares Outstanding, K 73,825
  • Annual Sales, $ 255,870 K
  • Annual Income, $ -103,270 K
  • EBIT $ -153 M
  • EBITDA $ -147 M
  • 60-Month Beta 1.63
  • Price/Sales 5.42
  • Price/Cash Flow N/A
  • Price/Book 4.21

Options Overview Details

View History
  • Implied Volatility 50.30% (-1.48%)
  • Historical Volatility 40.24%
  • IV Percentile 1%
  • IV Rank 1.52%
  • IV High 104.53% on 07/13/26
  • IV Low 49.46% on 09/04/25
  • Expected Move (DTE 9) 1.22 (6.57%)
  • Put/Call Vol Ratio 1.80
  • Today's Volume 524
  • Volume Avg (30-Day) 731
  • Put/Call OI Ratio 0.43
  • Today's Open Interest 18,127
  • Open Int (30-Day) 16,460
  • Expected Range 17.41 to 19.85

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/26
See More
  • Average Estimate $-0.70
  • Number of Estimates 3
  • High Estimate $-0.53
  • Low Estimate $-0.84
  • Prior Year $-0.45
  • Growth Rate Est. (year over year) -55.56%

Price Performance

See More
Period Period Low Period High Performance
1-Month
14.61 +27.52%
on 07/24/26
19.24 -3.17%
on 08/11/26
+2.14 (+12.98%)
since 07/10/26
3-Month
11.75 +58.55%
on 05/19/26
19.24 -3.17%
on 08/11/26
+5.94 (+46.81%)
since 05/12/26
52-Week
10.94 +70.21%
on 03/27/26
23.02 -19.07%
on 10/27/25
-0.22 (-1.17%)
since 08/12/25

Most Recent Stories

More News
Schrödinger Reports Second Quarter 2026 Financial Results

Second Quarter ACV of $30 Million, Representing 27% Growth Launched Early Access Version of Bunsen, A New Agentic AI Co-Scientist for Molecular Discovery

SDGR : 18.63 (-0.11%)
Schrödinger Announces Strategic Collaboration and Software Agreement with Bristol Myers Squibb to Deploy AI Co-Scientist Bunsen for Agentic Drug Discovery

Schrödinger, Inc. (Nasdaq: SDGR) today announced a strategic agreement with Bristol Myers Squibb (BMS) to deploy Bunsen, Schrödinger's agentic AI co-scientist, within its research organization....

SDGR : 18.63 (-0.11%)
Schrodinger's Drug Discovery Platform: Where Did All the Pharma Partnerships Go?

Barchart Research What to Expect from SDGR Earnings SDGR Generated August 4, 2026 Current Price $15.65 EPS Estimate $$-0.60 Consensus Rating Moderate Buy Average Move 3.28% Schrodinger's Drug Discovery...

SDGR : 18.63 (-0.11%)
Schrödinger Introduces Bunsen, an AI Co-Scientist for Molecular Discovery

Collaboration with NVIDIA and Google Cloud Provide Additional Tools and Compute Access

SDGR : 18.63 (-0.11%)
Schrödinger to Announce Second Quarter 2026 Financial Results on August 5

Schrödinger, Inc. (Nasdaq: SDGR) will report its second quarter 2026 financial results on Wednesday, August 5, 2026, after the financial markets close. The company will host a conference call...

SDGR : 18.63 (-0.11%)
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Schrödinger, Inc. (Nasdaq: SDGR) today reported that on July 16, 2026, the company granted restricted stock units (RSUs) with respect to 3,691 shares of the company’s common stock to four newly hired...

SDGR : 18.63 (-0.11%)
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Schrödinger, Inc. (Nasdaq: SDGR) today reported that on June 12, 2026, the company granted restricted stock units (RSUs) with respect to 10,771 shares of the company’s common stock to seven newly hired...

SDGR : 18.63 (-0.11%)
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Schrödinger, Inc. (Nasdaq: SDGR) today reported that on May 18, 2026, the company granted (i) a non-statutory stock option to purchase 1,875 shares of the company’s common stock to one newly hired employee...

SDGR : 18.63 (-0.11%)
A Breakout Year for WEE1? Oppenheimer Sees 6x Upside in This Under-the-Radar Biotech

Analysts have initiated bullish coverage of Aprea Therapeutics with price targets up to 6x current levels, citing the superior safety profile and $700M peak sales potential of its WEE1 inhibitor program...

AZN : 158.50 (-0.16%)
ZNTL : 4.29 (+4.38%)
ACRV : 1.7200 (-0.58%)
SDGR : 18.63 (-0.11%)
APRE : 0.6830 (+3.47%)
Schrödinger Reports First Quarter 2026 Financial Results

First Quarter ACV of $28 Million, Representing 12% Growth Continued Momentum in Transition to Hosted Software Licensing Schrödinger...

SDGR : 18.63 (-0.11%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strengthening short term outlook on maintaining the current direction.

Relative Strength is above 70%. The market is in overbought territory. Watch for a potential trend reversal.

See More Share

Business Summary

Schr'dinger Inc. provides computational platforms to accelerate drug discovery and materials design deployed by biopharmaceutical and industrial companies, academic institutions and government laboratories. Schr'dinger Inc. is based in NEW YORK.

See More

Key Turning Points

3rd Resistance Point 19.36
2nd Resistance Point 19.04
1st Resistance Point 18.84
Last Price 18.63
1st Support Level 18.32
2nd Support Level 18.00
3rd Support Level 17.80

See More

52-Week High 23.02
Last Price 18.63
Fibonacci 61.8% 18.41
Fibonacci 50% 16.98
Fibonacci 38.2% 15.56
52-Week Low 10.94

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.